These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 9078350)
1. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Lowry PA; Shultz LD; Greiner DL; Hesselton RM; Kittler EL; Tiarks CY; Rao SS; Reilly J; Leif JH; Ramshaw H; Stewart FM; Quesenberry PJ Biol Blood Marrow Transplant; 1996 Feb; 2(1):15-23. PubMed ID: 9078350 [TBL] [Abstract][Full Text] [Related]
2. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells. Hogan CJ; Shpall EJ; McNiece I; Keller G Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918 [TBL] [Abstract][Full Text] [Related]
3. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Shultz LD; Banuelos S; Lyons B; Samuels R; Burzenski L; Gott B; Lang P; Leif J; Appel M; Rossini A; Greiner DL Transplantation; 2003 Oct; 76(7):1036-42. PubMed ID: 14557749 [TBL] [Abstract][Full Text] [Related]
4. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733 [TBL] [Abstract][Full Text] [Related]
5. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation. Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349 [TBL] [Abstract][Full Text] [Related]
6. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection]. Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735 [TBL] [Abstract][Full Text] [Related]
8. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938 [TBL] [Abstract][Full Text] [Related]
9. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250 [TBL] [Abstract][Full Text] [Related]
10. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548 [TBL] [Abstract][Full Text] [Related]
11. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow. Wilpshaar J; Noort WA; Kanhai HH; Willemze R; Falkenburg JH Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407 [TBL] [Abstract][Full Text] [Related]
12. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model. Zheng Y; Sun A; Han ZC Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197 [TBL] [Abstract][Full Text] [Related]
13. Good engraftment of B-cell precursor ALL in NOD-SCID mice. Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448 [TBL] [Abstract][Full Text] [Related]
15. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Ramírez M; Rottman GA; Shultz LD; Civin CI Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317 [TBL] [Abstract][Full Text] [Related]
16. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice]. Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577 [TBL] [Abstract][Full Text] [Related]
17. A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment. Angelopoulou MK; Rinder H; Wang C; Burtness B; Cooper DL; Krause DS Transfusion; 2004 Apr; 44(4):555-66. PubMed ID: 15043572 [TBL] [Abstract][Full Text] [Related]
18. In vivo engraftment potential of clinical hematopoietic grafts. Leung W; Ramírez M; Novelli EM; Civin CI J Investig Med; 1998 Aug; 46(6):303-11. PubMed ID: 9737093 [TBL] [Abstract][Full Text] [Related]
19. Enhanced in vivo motility of human umbilical cord blood hematopoietic stem/progenitor cells introduced via intra-bone marrow injection into xenotransplanted NOD/SCID mouse. Gao J; Li Y; Lu S; Wang M; Yang Z; Yan X; Zheng Y Exp Hematol; 2009 Aug; 37(8):990-7. PubMed ID: 19481136 [TBL] [Abstract][Full Text] [Related]
20. Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model. Ural SH; Sammel MD; Blakemore KJ Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):990-4. PubMed ID: 16157099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]